How should orthostatic hypotension be defined, diagnosed, and initially managed?

Orthostatic Hypotension: Definition, Diagnosis, and Initial Management

Definition and Diagnostic Criteria

Orthostatic hypotension is diagnosed when systolic blood pressure drops ≥20 mmHg or diastolic blood pressure drops ≥10 mmHg within 3 minutes of standing, or when systolic pressure falls to <90 mmHg absolute. 1

Modified Criteria for Specific Populations

• In patients with baseline supine hypertension, use a more stringent threshold of ≥30 mmHg systolic drop to avoid overdiagnosis. 1

Subtypes Based on Timing

• Classical orthostatic hypotension: Blood pressure drop meeting criteria within 3 minutes of standing. 1
• Initial orthostatic hypotension: Transient drop >40 mmHg systolic and/or >20 mmHg diastolic within the first 15 seconds of standing, with rapid recovery within 40 seconds. 1
• Delayed orthostatic hypotension: Blood pressure drop meeting standard criteria but occurring beyond 3 minutes of standing, with slow progressive decrease; this variant carries a 29% ten-year mortality rate. 1

---

Measurement Protocol

Patient Preparation

• Patient must fast for 3 hours before testing. 1
• Avoid nicotine, caffeine, theine, or taurine-containing drinks on the day of examination. 1
• Conduct testing in a temperature-controlled environment (21–23°C). 1

Step-by-Step Measurement Technique

1. Rest the patient supine or sitting for 5 minutes before baseline measurement. 1
2. Measure baseline blood pressure in both arms at the first visit using a validated, calibrated device with appropriate cuff size. 1
3. If systolic blood pressure differs by >10 mmHg between arms, use the arm with higher blood pressure for all subsequent measurements. 1
4. Have the patient stand and measure blood pressure and heart rate at 1 minute after standing. 1
5. Measure again at 3 minutes after standing. 1
6. Maintain the arm at heart level during all measurements. 1
7. If blood pressure continues to decline at 3 minutes, continue measurements until values stabilize. 1

Critical Timing Considerations

• Measuring blood pressure immediately after standing fails to capture sustained changes required for diagnosis of classical orthostatic hypotension, leading to false-negative results. 1
• Both 1-minute and 3-minute measurements are mandatory—measuring only at 1 minute misses a substantial proportion of cases, particularly in elderly patients on antihypertensives or dopaminergic agents. 1
• For symptomatic patients with negative initial testing, extend standing time to 10 minutes to detect delayed orthostatic hypotension. 1
• Population data show that only 46% of individuals with orthostatic hypotension demonstrate it within 3 minutes, 15% between 3–10 minutes, and 39% only after 10 minutes. 1

---

Distinguishing Neurogenic from Non-Neurogenic Causes

Heart Rate Response as Key Differentiator

• Neurogenic orthostatic hypotension: Heart rate increase is blunted (<10 beats per minute) upon standing due to impaired autonomic control. 1, 2
• Non-neurogenic orthostatic hypotension (e.g., hypovolemia): Heart rate increase is preserved or enhanced. 1, 2

Neurogenic Causes

• Primary autonomic failure: Parkinson's disease, multiple system atrophy, pure autonomic failure, dementia with Lewy bodies. 3, 2
• Secondary autonomic neuropathies: Diabetes mellitus (most common), amyloidosis, spinal cord injuries, autoimmune autonomic neuropathy. 3, 2
• The fundamental defect is failure of peripheral vascular resistance to increase appropriately upon standing, resulting in inadequate vasoconstriction. 3

Non-Neurogenic Causes

• Medications (most frequent cause overall): Diuretics, vasodilators (including nitrates), alpha-adrenergic blockers, beta-blockers, psychotropic drugs. 3, 2
• Volume depletion: Excessive diuresis, dehydration, blood loss. 3
• Severe arteriosclerosis: Pseudohypertension in elderly patients with calcified arteries may lead to overtreatment of hypertension and iatrogenic orthostatic hypotension. 3, 2

---

Diagnostic Workup

Essential Initial Evaluation

• Medication review: Identify and assess all vasoactive drugs—this is the most important reversible cause. 2
• Volume status assessment: Evaluate for dehydration, blood loss, or excessive diuresis. 3
• Neurological examination: Look for signs of autonomic dysfunction, Parkinsonism, or peripheral neuropathy. 3

Additional Testing When Indicated

• ECG: Rule out arrhythmias contributing to symptoms. 1
• 24-hour ambulatory blood pressure monitoring: Detect patterns of blood pressure variability and identify supine hypertension (common in neurogenic orthostatic hypotension). 1
• Echocardiography: Only if cardiac cause is suspected with clinical evidence of cardiac disease—diagnostic yield is low without clinical suspicion. 1
• Autonomic testing (Valsalva maneuver, deep-breathing testing): When neurogenic orthostatic hypotension is suspected. 2

Common Pitfall to Avoid

• Do not routinely order echocardiography in the absence of clinical cardiac findings—orthostatic hypotension is primarily a problem of autonomic nervous system dysfunction and vascular regulation, not a primary cardiac disorder. 3

---

Initial Management

Step 1: Non-Pharmacologic Interventions (Mandatory for All Patients)

• Compression garments extending to at least the thigh and preferably including the abdomen improve orthostatic symptoms and blunt blood pressure falls. 1
• Acute water ingestion of ≥480 mL provides temporary symptom relief, with maximal pressor effect occurring about 30 minutes after intake. 1
• Physical counter-pressure maneuvers: Leg crossing, lower-body muscle tensing, maximal hand-grip, squatting can raise standing blood pressure. 1
• Increase dietary salt and fluid intake in selected patients without contraindications (heart failure, renal disease). 1

Step 2: Medication Review and Adjustment

Do not discontinue all antihypertensives when orthostatic hypotension is detected—untreated hypertension carries substantially higher cardiovascular morbidity and mortality than the risks posed by orthostatic hypotension. 1

Medication Switching Strategy

• Identify the antihypertensive most likely to provoke orthostatic hypotension and switch it to an alternative class with lower orthostatic risk. 1
• Preferred antihypertensive classes with lower orthostatic hypotension incidence:
  • Renin-angiotensin system blockers (ACE inhibitors or ARBs). 1
  • Dihydropyridine calcium-channel blockers. 1
• Avoid simultaneous initiation of two antihypertensive drugs in elderly patients; if dual initiation is necessary, monitor closely for orthostatic hypotension. 1
• Use slow titration schedules for dose adjustments in patients with prior orthostatic symptoms. 1

Monitoring After Medication Changes

• Re-measure orthostatic vital signs at 1,3, and 6 months after any medication change to ensure resolution or improvement. 1

Step 3: First-Line Pharmacologic Therapy (When Non-Pharmacologic Measures Are Insufficient)

Midodrine

• Improves orthostatic symptoms in a dose-dependent manner, typically raising standing blood pressure. 1
• Common adverse effects: Supine hypertension, scalp tingling, piloerection, urinary retention. 1

Droxidopa

• Improves symptoms of neurogenic orthostatic hypotension associated with Parkinson's disease, pure autonomic failure, and multiple system atrophy. 1
• Small studies suggest droxidopa may reduce fall frequency. 1
• Important interaction: Concomitant carbidopa therapy in Parkinson's disease can diminish droxidopa effectiveness. 1
• Adverse effects: Supine hypertension, headache, dizziness, nausea. 1

Step 4: Second-Line Therapy

Fludrocortisone

• Expands plasma volume and can improve orthostatic symptoms when first-line agents are ineffective or not tolerated. 1
• Potential side effects: Supine hypertension, peripheral edema, hypokalemia, headache; at doses >0.3 mg/day, serious adverse events such as adrenal suppression and immunosuppression. 1
• Strength of recommendation: Weak, based on very low-quality evidence. 1

Step 5: Refractory Cases

• Pyridostigmine: May be beneficial for patients who remain symptomatic despite standard therapy (weak recommendation, very low-quality evidence). 1
• Octreotide: May help refractory neurogenic or post-prandial orthostatic hypotension (weak recommendation, low-quality evidence). 1

---

Clinical Pearls and Caveats

• Symptoms depend more on the absolute blood pressure level reached than the magnitude of the fall—a patient dropping from 180/100 to 150/80 mmHg may be asymptomatic despite meeting diagnostic criteria. 2
• Asymptomatic orthostatic hypotension should not be ignored: Even without symptoms, orthostatic hypotension is linked to a 64% increase in age-adjusted mortality and higher fall risk. 1, 3
• Prevalence: Orthostatic hypotension occurs in approximately 10% of all hypertensive adults, 30% of patients over 65 years, and up to 50% of older institutionalized adults. 1, 2
• Intensive blood pressure lowering treatment actually reduces the risk of orthostatic hypotension, possibly due to improvement in baroreflex function and reduced arterial stiffness—asymptomatic orthostatic hypotension during hypertension treatment should not trigger automatic down-titration of therapy. 3
• Neurogenic orthostatic hypotension may be the earliest clinical manifestation of Parkinson's disease or related synucleinopathies and often coincides with supine hypertension. 4